Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basic versus Advanced Basal Plus insulin intensification with insulin aspart added to insulin detemir and oral antidiabetic drugs in type 2 diabetes
2007-000123-18Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- May 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart and insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: HbA1c at 36 weeks. Started May 2007; status: completed.
02
Drugs
insulin aspartinsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-000123-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000123-18.